All articles by Phillip Broadwith – Page 2
-
OpinionResistant to change
Curbing industrial practices that drive antimicrobial resistance needs tighter regulation and enforcement
-
BusinessAntibodies face Alzheimer’s reality
Companies are convincing regulators, but will doctors use them, and will providers pay for them?
-
OpinionWho knew what? And when?
Finding the line between commercially sensitive information and public and environmental protection
-
BusinessRecycling plastic with enzymes
Carbios can return even hard-to-recycle polyester fibres and textiles to their constituent monomers
-
ResearchAromatic molecules in a galaxy far, far away
JWST IR observations suggest star formation was rapid and uneven in early galaxy
-
BusinessDeadly explosion and fire at US pharmaceutical plant
One worker killed and four hospitalised at Seqens in Newburyport
-
BusinessFive dead after explosion at plant in China
Blast in hydrogen peroxide unit of Sinochem plant in Liaocheng
-
OpinionBattery materials going up in smoke
We cannot afford to simply throw away, rather than recycle, these valuable resources
-
BusinessMerck & Co to buy immunology specialist Prometheus
$10.8 billion cash deal give Merck rights to late-stage candidate for two inflammatory bowel conditions
-
BusinessGhana and Nigeria approve Oxford malaria vaccine
Approval comes before final-stage clinical trials have been completed
-
OpinionHolding the keys to a powerful future
Competition to build battery supply chains means supercharging support to attract investment
-
BusinessFragrance firms face coordinated cartel probe
Givaudan, Firmenich, Symrise and IFF raided by competition authorities
-
-
BusinessFatal explosion and fire at chemical plant in China
Five dead, a further eight missing, and 30 more injured at Panjin Haoye Chemical
-
BusinessAt least 38 killed in industrial fire in China
Sparks from welding work appear to have ignited textiles at the plant
-
OpinionElizabeth Holmes to be imprisoned for Theranos fraud
Blood testing company founder’s 11-year sentence should serve as a warning to investors
-
BusinessAlzheimer’s antibody engenders anticipation
Tantalising press-released data on Biogen and Eisai’s lecanemab prompt questions without firm answers
-
BusinessRocket-powered carbon dioxide conversion
Barton Blakeley is lowering the carbon footprint of silica and other materials
-
BusinessJ&J to phase out talc-based baby powder worldwide
In the face of thousands of lawsuits, firm will switch to cornstarch-based formulations
-
BusinessAt least 13 dead in massive chlorine release in Jordan
Tanker of gas fell during loading at the port of Aqaba, injuring hundreds